Radiant energy – Radiation controlling means
Reexamination Certificate
2011-07-19
2011-07-19
Nguyen, Kiet T (Department: 2881)
Radiant energy
Radiation controlling means
C250S492300
Reexamination Certificate
active
07982200
ABSTRACT:
Treatment planning methods are provided that determine the variability of relative biological effectiveness (RBE) along a beam line and calculate, among other things, what intensity of hadron beam such as a proton or a carbon ion beam should be applied to achieve a desired biological dose at treatment site of a patient afflicted with a medical condition. Typically, three or four RBE values at three or four corresponding spacially-dispersed intervals along the beam line are calculated. In one embodiment, two RBE values for the spread-out Bragg peak (SOBP) region of the treatment site; one for the proximal section and one for the declining distal section is calculated. A third and different RBE value may be determined for the distal edge region of the SOBP. A fourth value may also be calculated for a pre-SOBP region.
REFERENCES:
patent: 7268358 (2007-09-01), Ma et al.
patent: 2006/0145088 (2006-07-01), Ma et al.
patent: 2008/0164416 (2008-07-01), Safai
patent: 2009/0060130 (2009-03-01), Wilkens et al.
Matsubara S, Ohara H, Hiraoka T, Koike S, Ando K, Yamaguchi H, Kuwabara Y, Hoshina M, Suzuki S,, “Chromosome aberration frequencies produced by a 70-MeV proton beam”, Radiat. Res. 123:182-91, 1990.
Erik Blomquist, Kellie R. Russell, Bo Stenerlöw, Anders Montelius, Erik Grusell and Jörgen Carlsson, “Relative biological effectiveness of intermediate energy protons. Comparison with 60Co gamma-radiation using two cell lines”, Radiother. Oncol, 28:44-51, 1993.
Courdi A., Brassart N., Herault J., and Chauvel P., “The depth-dependent radiation response of human melanoma cells exposed to 65-MeV protons”, Brit. J. Radiol., 67: 800-4, 1994.
Gueulette J, Gregoire V, Octave-Prignot M, Wambersie A., “Measurements of radiobiological effectiveness in the 85-MeV proton beam produced by the cyclotron CYCLONE of Louvain-La Neuve,”Belgium. Radiat. Res. 145:70-4, 1996.
Wouters B. G., Lam G. K. Y., Oelfke U., Gardey K., Durand R. E. and Skarsgard L. D., “Measurements of relative biological effectiveness of the 70-MeV proton beam at TRIUMF using Chinese hamster V97 cells and the high precision cell sorter assay,” Radiat. Res., 146:159-70, 1996.
Tang JT, Inoue T, Inoue T, Yamazaki H, Fukushima S, Fournier-Bidoz N, Koizumi M, Ozeki S, Hatanaka K., “Comparison of radiobiological effective depths in 65-MeV modulated proton beams”, Brit. J. Cancer, 76:220-5, 1997.
Paganetti H., Olko P., Kobus H., Becker R., Schmitz T., Waligorski M.P.R., Filges D., and Hans-Wilhelm Muler-Gartner, “Calculation of Relative Biological Effectiveness for Proton Beams Using Biological Weighing Functions”, Int. J. Radiat. Oncol. Biol. Phys., 37:719-29, 1997.
Paganetti H, Schmitz Th, “The influence of the beam modulation technique on dose and RBE in proton radiation therapy”, Phys. Med. Biol. 41:1649-63, 1996.
Bettega D, Caizolari P, Chauvel P, Courdi A, Herault J, Iborra N, Marchesini R, Massariello P, Poli GL, Tallone L., “Radiobiological studies on the 65-MeV therapeutic proton beam at Nice using tumor cells”, Int J Radiat Biol. 76: 1297-1303, 2000.
Petrovic I, Ristic-Fira A, Todorovic D, Valastro L, Cirrone P, Cuttone G., “Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beam”, Int J Radiat Biol. 82: 251-65, 2006.
Paganetti H, Goitein M., “Biophysical Modeling of Proton Radiation Effects Based on Amorphous Track Models”, Int. J. Radiation Biology, 77: 911-28, 2001.
Paganetti H., Niemierko A., Ancukiewicz M, Gerweck L.E., Goitein M, Loeffler J.S. and Suit H.D., “Relative biological effectiveness (RBE) values for proton beam therapy”,Int. J. Radiat. Oncol. Biol. Phys., 53: 407-21, 2002.
Paganetti H., “Significance and implementation of RBE variations in proton beam therapy”, Technology in Cancer Research & Treatment, 2:413-26, 2003.
Paganetti H., Jiang H., Adams J.A., Chen G.T. and Rietzel E. “Monte-Carlo simulations with time-dependent geometries to investigate effects of organ motion with high temporal resolution”,Int. J. Radiat. Oncol. Biol. Phys., 60: 942-50, 2004.
Tilly N., Johansson J., Isacsson U., Medin J., Blomquist E., Grusell E. and Glimelius B.. “The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer,” Phys. Med. Biol. 50:2765-77, 2005.
Weyrather WK, Kraft G., “RBE of carbon ions: experimental data and the strategy of RBE calculation for treatment planning”,Radiother. Oncol, 73: 161-9, 2004.
Scholz M., Kellerer A.M., Kraft-Weyrather W., Kraft G., “Computation of cell survival in heavy ion beams for therapy. The model and its approximations”, Radiat. Environ. Biophys., 36: 59-66, 1997.
Kramer M, Jakel O., “Biological dose optimization using ramp-like dose gradients in ion irradiation fields”, Physica Medica, XXI, 107-11, 2005.
O. Jakel et al., “Treatment planning for carbon ion radiotherapy in Germany: Review of clinical trials and treatment planning studies”, Radiother. Oncol. 73: S86-S91, 2004.
Blakely EA, Chang PY., “Late effects from hadron therapy”,Radiother. Oncol, 73: S134-140, 2004.
Slater J.D., Yonemoto L.T., RossiJr C.J., Reyes-Molyneux N.J., Bush D.A., Antoine J.E., Loredo L.N., Schulte R.W.M., Teichman S.L. and Slater J.M., “Conformal proton therapy for prostate carcinoma,” Int. J. Radiat. Oncol. Biol. Phys. 42: 299-304, 1998.
Wilkens JJ, Oelfke W., “Optimization of radiobiological effects in intensity modulated proton therapy”, Med. Physics, 32: 455-65, 2005.
Kraft, G., “Tumor Therapy with Heavy Charged Ions”, Progr. Part. Nucl. Phys., 45, 473-544, 2000.
Kraft G., “RBE and its Interpretation”, Strahlenther. Onkol., 175, Suppl 2, 44-47, 1999.
Lomax A., “Intensity modulation methods for proton radiotherapy”, Phys. Med. Biol. 44: 185-205, 1999.
Antony J. Lomax, Thomas Bortfeld, Gudrun Goitein, Juergen Debus, Christine Dykstra, Pierre-Alain Tercier, Philippe A. Coucke and Rene O. Mirimanoff. “A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy,” Radiotherapy and Oncology, 51, 257-271, (1999).
Lomax AJ, Boehringer T, Coray A , Egger E, Goitein G, Grossmann M, Juelke P, Lin S, Pedroni E, Rohrer B, Roser W, Rossi B, Siegenthaler B, Stadelmann O, Stauble H, Vetter C, and Wisser L. “Intensity modulated proton therapy: A clinical example,” Medical Physics, 28, 317-324, (2001).
Paganetti H and Bortfeld T., “Proton Beam Radiotherapy—The State of the Art,” To be published in: New Technologies in Radiation Oncology (Medical Radiology Series), (Eds.) W. Schlegel, T. Bortfeld and A.-L. Grosu, Springer Verlag, Heidelberg, ISBN 3-540-00321-5, Oct. 2005.
Bortfeld Th, Bürkelbach J, Boesecke R and Schlegel W, “Methods of image reconstruction from projections applied to conformation radiotherapy,” Phys. Med. Biol., 35, 1423-34, (1990).
Gustafsson A, Lind BK, Brahme A., “A generalized pencil beam algorithm for optimization of radiation therapy”, Med. Physics, 21: 343-56, 1994.
Llacer J., “Inverse radiation treatment planning using the dynamically penalized likelihood method”, Med. Physics, 24: 1751-64, 1997.
Brahme A., “Optimized radiation therapy based on radiobiological objectives”, Semin. Radiat. Oncol., 9: 35-47, 1999.
Wang XH, Mohan R, Jackson A, Leibel SA, Fuks Z, Ling CC., “Optimization of intensity-modulated 3D conformal treatment plans based on biological indices,” Radiother. Oncol., 37: 140-152, 1995.
Brahme A, Ross J, Lax I., “Solution of an integral equation in rotation therapy”, Phys. Med. Biol, 27: 1221-1229, 1982.
Cormack A., “A problem in rotation therapy with x-rays”, Int. J. Radiat. Oncol. Biol. Phys., 13:623-30, 1987.
Oelfke U, Bortfeld T., “Inverse planning for photons and proton beamsȁ
Britten Richard A.
Keppel Cynthia E.
Nazaryan Vahagn R.
Hampton University
McGuireWoods LLP
Nguyen Kiet T
LandOfFree
Hadron treatment planning with adequate biological weighting does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hadron treatment planning with adequate biological weighting, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hadron treatment planning with adequate biological weighting will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2731880